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Abstract
Drug abuse has expanded from more well-known substances, such as cocaine and
marijuana, to relatively new novel psychoactive substances. A group of these substances called
synthetic cannabinoids have been increasing in usage throughout the 2000's, and these
compounds carry significant and varying risks depending on the dose and composition of the
synthetic cannabinoid. Patients have been observed having symptoms associated with high doses
of synthetic cannabinoids when they take lower doses of the synthetic cannabinoid in addition to
their antidepressant medication. In order to test the etlects of co-administration of selective
serotonin reuptake inhibitors (SSRis) and synthetic cannabinoids, mice were observed in a
marble burying assay under the influence of the different drugs. Mice were given either
fluoxetine (1 0-mg/kg), citalopram (20-mg/kg), or JWH-0 18 (0.1-mg/kg or 0.3-mg/kg) or a
combination of the drugs. Mice without being injected with any of the drugs bw-ied 6.375
marbles on average in the twenty-minute test. Mice injected with fluoxetine or citalopram alone
buried 4.25 marbles and 4.0 marbles respectively. The JWH-018 doses were chosen to be
ineffective so that the marbles buried at 0.1-mg/kg was 6.125 and the 0.3-mg/kg dose resulted in
6.375 marbles buried. Fluoxetine in combination with JWH-018 resulted in 3.0 marbles being
buried for the lower dose and 1.875 marbles were buried with the high dose. Citalopram in
combination with JWH-0 18 resulted in 3.625 marbles buried for the lower dose and 2.875
marbles buried for the high dose. When the SSRis were taken with an ineffective dose of JWH0 18 a greater than anticipated drug effect occwTed, since it occurred in both combinations it
points to a phannacodynamic effect instead of a phatmacokinetic effect.
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Background
There are approximately two hundred scheduled drugs internationally, but there are over
seven hundred other substances that are available. These drugs are called new psychoactive
substances and are largely unregulated (National Institute of Abuse, 20 15). These substances
include but are not limited to both synthetic cathinones and synthetic cannabinoids. Both of
these groups are becoming increasingly prevalent in drug abuse and are significant risks to public
health, especially in young people (Office of Drug Control Policy).
In the past few years synthetic drugs have been in the news more frequently. The use of
synthetic cathinones, also known as bath salts, has led to dramatized news reports of individuals
involved in grisly acts of violence against others (ABC News, 2012). Synthetic cannabinoids on
the other hand have not seen as many sensationalized news articles, which adds to a perception
of safety that abusers see in the drugs. Abusers also see that marijuana is beginning to be
legalized and used medically, so people think the synthetic cannabinoids are "synthetic
mruijuana", a safe and legal alternative. In a 2012 Monitoring the Future Survey, 11.3% ofhigh
school seniors reported using some type of synthetic cannabinoids (National Institute of Abuse,
20 15). On the other hand, bath salts are perceived as more dangerous so only 1.3% of high
school seniors repmted having used bath salts (Seeley et al., 20 13).
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Figure 1: Active Ingredient in Marijuana, A9-THC
One of the most dangerous aspects of synthetic cathinones is the different effects that
can occur from different derivatives. Synthetic cathinones have been known to mimic the effects
of several big name illicit drugs for example methylenedioxypyrovaJerone (tviDPV) mimics the
effects of cocaine. Other cathinones seem to be similar to MDMA (ecstasy) and
methamphetamine. Synthetic carmabinoids on the other hand are seen only as "fake weed" but it
has varying effects similar to synthetic cathinones.
The ability of synthetic cannabinoids to have multiple effects is problematic for
healthcare. For example, in Brunswick, Georgia dming late August and early September 2013
twenty-two patients were admitted to emergency departments for synthetic cannabinoid use.
Patients experienced a variety of symptoms from the drug abuse including hyperglycemia,
hyperkalemia; acidosis, tachycardia, nausea, vomiting, confusion or disorientation, aggression,
unresponsiveness and seizures. Some ofthese patients experienced complications of pneumonia
(two), rhabdomyolysis (one), and myocardial infarctions (one). Certain patients were admitted to
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intensive care units and some required assisted ventilation. The huge variety of effects that
resulted from synthetic cannabinoid use for these patients resulted from the same product, called
"Crazy Clown", that was bought from the same smoke shop (Dreznek, 20 13).
This example is only the effects of one synthetic cannabinoid product from one smoke
shop in one state. The United Kingdom National Poisons Information Service (UKNPIS) used a
survey that lasted for eight years to identify different effects that have resulted from synthetic
cannabinoid abuse. In addition to the variety of effects that were seen in Georgia, the UK survey
uncovered symptoms such as abdominal pain, chest pain, hypotension, arrhythmia, speech
disorders, and more (Waugh, et al, 2016). The increase in symptoms found by the UKNPTS may
be a function of different products, since the most popular synthetic cannabinoid products in the
survey were Black Mamba, Clockwork Orange, and Pandora's Box, not Crazy Clown (Waugh,
et al, 20 16).
Synthetic cannabinoid products that are sold, such as K2, Spice, or Crazy Clown, are
unpredictable because they can contain one or many different synthetic cannabinoids. The reason
synthetic drugs can be easily altered by changing only side groups on the original chemical
resulting in many compounds that have varying effects. Figure 2 shows how many different
synthetic cannabinoids, each of which has a slightly different structure and slightly different
effects (Tai and Fantegrossi, 20 16). The ease in which the drug composition can change helps
people to avoid drug enforcement. The tests for drugs are typically done by taking blood or
urine samples followed by immunoassays and mass spectrometry assays. The problem is that
assays are too specific to identify all of the new compounds. Antibodies for immunoassays are
too specific and even if we had less specific antibodies that could identify the main components
of synthetic cannabinoids the mass spectrometry would still need to be specific. The mass
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spectrometry needs the initial structure and its metabolites to work which with many of these
synthetic cannabinoids isn't possible. The mass spectrometry is required as a confirmation in
case the immunoassay results in a false positive. Without it the whole test is ineffective
(Strickland and Bazydlo, 20 18).
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Figure 2: Variety of Synthetic Cannabinoids
Another problem that occurs with synthetic cannabinoids is that they can be more
efficacious and potent than marijuana. Figure 3 illustrates how two synthetic cannabinoids are
more efficacious than marijuana. Efficacy is the ability of a compound to bind the receptor,
because for a drug to be effective it has to be able to bind the receptor. In Figure 2 the lines of
best fit for JWH-018 and JWH-073 are both shifted to the left of the Jine of best fit for THC,
which is the active compound in marijuana. The shift to the left means that it takes less substrate
(on the horizontal access) to have the same amount of receptor binding as THC, therefore the
two synthetic cannabinoids are more efficacious than THC.

7

en

Competition Receptor Binding
(Mouse Brain)

120

s::

·"C

.5

100

m
0

~ 80
en-

•

CP

&()..

•

THC

0

JWH-018

•

JWH~073

E

~t: 60
(.)0
D..O
I

,......~
40
::J:C
M._..

......

·-

20

c.

0

~

(J

G>

tn

1o-13 1o- 12 1o-11

1o- 10

1o-9

1o-8

1o-7

1o-6

1a-s

[Competitor, M]
Figure 3: Comparative Receptor Binding Affinity
Figure 4 also shows how the same two drugs are more efficacious, but in a different way.
Once the CaiJllabinoid binds to the receptor it activates a G-protein that then causes a signal
cascade in the cell. The G-protein activation of JWH-018 and JWH-073 are shifted left ofTHC,
but JWH-073 is much less obvious in this graph. The shift left again means that less substrate is
needed for the synthetic cannabinoids to bjnd to the cannabinoid receptors and therefore means it
is more efficacious. The Jines of best fit for G-protein activation for the two synthetic
cannabinoids are also shifted vertically on the graph, which means that for the same amount of
substrate the synthetic cannabinoid has a greater effect. This increase in effect is referred to as
the potency of the drug, so the synthetic cannabinoids are more potent than THC.
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Figure 4: Comparative G-Protein Activation

The increase in efficacy and potency of synthetic cannabinoids as opposed to THC is
where the increased likelihood of negative health effects lies. The effect of marijuana and many
medicines has been tested and is mostly well known, but synthetic cannabinoids could interact
with drugs that marijuana does not. Rumors of patients coming into hospitals with high dose
effects of synthetic cannabinoids when taking low doses of synthetic cannabinoids with selective
serotonin reuptake inhibitors (SSRis), a group of antidepressant medications, resulted in the
following experiments.
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Experiments
Hypotheses
General Hypotheses. Synthetic cannabinoids when co-administrated with SSRis will
result in a larger than anticipated drug effect. The larger than anticipated drug effect resulting
from the co-administration will be due to a pharmacokinetic effect involving the enzymatic
breakdown of the two compounds.

Experimental Hypotheses. An ineffective dose of JWH-018 when co-administered with
an effective dose of the SSRI fluoxetine will result in less marbles buried than with only
fluoxetine. The larger than anticipated drug effect will be due to a pharmacokinetic effect
involving the cytochrome 2C9 that breaks down both fluoxetine and JWH-018.

Methods
All methods were canied out as recommended by the Public Health Service Policy on
Humane Care and Use of Laboratory Animals ofthe National Institute of Health. The protocols
were approved by the Department of Laboratory Animal Medicine at the University of Arkansas
for the Medical Sciences.

Protocols.
1. Standard plastic mouse cages were used for the marble burying test. Fresh standard
bedding added to the cages from 3-cm to 5-cm in depth. Plastic filter tops were placed on
cages to prevent mice from escaping during the tests. Wire racks that hold food and water
were withheld during the tests.
2. Ten standard glass marbles arranged on top of the bedding approximately equidistant in
the same pattern for every cage (see Figure 6). Before the marbles were placed in the
cages, they were cleaned and dried to remove scents of earlier experiments.
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3. Stopwatches were set for twenty minutes, but results were checked and recorded every
five minutes.

4. Each mouse was injected intraperitoneally before the test with the dose depending on the
compound(s) being tested. Then the mouse was given a treatment time to allow the
effects of the drug to occur, which was also dependent on the compound injected.

The Laboratory Mouse. Unffl<r.vity ofllfinois at Chicago, 20 I 4.

Figure 5: Intraperitoneal Injection of Mouse
5. A single mouse was then set into each cage and left undisturbed for twenty minutes.
After the twenty minutes the mice were returned to their home cages.

6. The marbles were then examined and those that were buried over half their height were
counted.
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Figure 6: Example Marble Burying Test with Saline

Figure 7: Example Marble Burying Test with SSRJ
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Pre-Experiment. Before the main experiments began there were several tests to ensure
that the marble burying assay would work for the planned experiment. Firstly, the SSRis
fluoxetine was tested at the dose 10-mg/kg with a thirty-minute treatment time to give a baseline
effect of the SSRis. Then citalopram was tested at 10-mg/kg and 20-mg/k.g with treatment times
of thirty-minute and one-hour treatment times in order to fmd an effect that was similar to the
effect of fluoxetine at 10-mg/kg. The 20-mg/kg dose was chosen to be used for the later tests
with a treatment time of thirty-minutes. The chosen doses of fluoxetine and citalopram had
nearly equivalent effects on marble burying, but if the JWH-018 interacted in later test~ we
would still be able to see change in either direction (agonistic or antagonistic interaction effects).
Then tests were run to confirm the ineffective doses of .JWH-018 from 0.1-mg/kg, 0.3mg/kg and 1.0-mg/kg with a thirty-minute treatment time. Both 0.1-mg/kg and 0.3-mg/kg were
found to have no effect on the marble burying test, but the 1.0-mg/kg dose was eliminated due to
interference with the ability of the mice to bury marbles.
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Figme 8: Repeated Saline Trials
The final pre-experiment test was to find if the marble burying test could be used
repeatedly without having an effect on results. This would determine if the same mice could be
used in a longitudinal experiment, so that they could be used as controls against themselves. In
order to test that we gave a group of 8 mice saline inj ections, and then they were subjected to the
marble burying test. The same group of 8 mice repeated this test with saline from between 10:00
am and 12:00 pm every day for six days. The results of all 8 mice were averaged for each day
and the results were recorded in Figure 8. 1bere was no significant difference in the results of
tests over the course of the six days, so we decided to continue with the longitudinal experiment
design.
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Experiment. The main experiment was run with eight mice, which were included in all
of the tests. The design of the experiment was longitudinal, meaning that the same mice were
used over a relatively long period of time so that the results of earlier tests can be used as
controls for the future tests. The longitudinal experiment design is illustrated in Figure 9.

Control Test
(No Drug/
Saline)

First Drug
(SSRI)

2 Days of
Vehicle Test

Second Drug
Test (JWH-

018)

2 days of
Vehicle Test

Combintation
Drug Test

Figure 9: Longitudinal Experiment Design
First the mice went through two control tests. The first control test was with no drug to
see what a mouse would normally do when presented with the marbles. Then the second test
was with saline in order to see if discomfort or aggravation from the injection would change the
results of the marble burying test. These tests were used as a baseline to compare the results of
the drugs later tested as can be seen in Figure 10.
The day after the control testing was finished, the SSRl drugs were tested. The first test
was with the 10-mg/kg dose of tluoxetine with a thirty-minute treatment time, and then the mice
were tested with 20-mg/kg of citalopram with a thirty-minute treatment time. These tests allowed
us to have a baseline drug effect for SSRTs to compare with our interaction tests. Between the
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tests with the SSRI injections two days of saline tests were run in order to allow each drug time
to washout. This prevented residual drugs in the mouse from influencing the results of later
experiments.
After the SSRI tests and the final two-day washout period for them, the mice began the
two JWH-018 tests. The tirst test was with JWH-018 at 0.3-mglkg with a thirty-minute
treatment time. Two days of saline tests were then administered. After the washout period the
second test was nm with JWH-0 18 at 0.1-mg/kg with a thirty-minute treatment time. The two
synthetic cannabinojd tests were run in order to confirm that the doses did not affect the marble
burying test in the same way as it did in previous tests.
After the final JWH-0 18 test the mice were again given a two-day washout period before
beginning the final portion of the experiments. The next tests conducted were the JWH-0 I 8 0.3-

mg/kg dose with the two doses of SSRJs. First the SSRI was injected and immediately afterward
the JWH-018 dose was injected into the mouse. After the mouse was injected a thirty-minute
treatment time was observed before the mice began the marble burying test. Between each
combination test the same two-day washout period was observed. After the high dose of JWH018 was tested, the same was done for the 0.1 -mg/k.g dose.

Post Experiment. After the tests in the main experiment were completed an additional
test was run to give additional data on whether an interaction discovered would be
pharmacokinetic or phannacodynamic. In the test, the mice were given the 0.3-mg/kg dose of
JWH-018, a 10-mg/kg dose offluoxetine, and a 10-mg/kg dose ofrimonabant. The antagonist
rimonabant was added to the test to block any pharmacodynamic effect, so if there was no
change to marble burying the interaction was pharmacokinetic, but if there was a change with the

rimonabant it would be p harmacodynamic.
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Results
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Figure 10: Average Marbles Buried for Various Treatments
When the mice were given only saline the mice buried on average 6.375 marbles. When
mice were injected with the O.l~mglkg dose of JWH-018 6.125 marbles were buried on average
and at 0.3-mg/kg 6.375 marbles were buried on average. Neither of these values reflects a
significant difference from the saline control group. The fluoxetine dose of 1O~mg/kg resulted in
an average of 4.25 marbles buried, and the citalopram dose of20-mg/kg resulted in an average of
4.0 marbles buried. Both of the SSRis caused the marble burying to decrease significantly from
the control group. The SSRI effects are not significantly different than each other. Fluoxetine in
combination with both doses of JWH-018 caused a decrease in marble burying. The combination
offluoxetine with the 0.1-mg/kg dose of JWH-018 resulted in 3.0 marbles being buried on
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average, and the 0.3-mg/kg dose of JWH-0 18 resulted in 1.875 marbles being buried on average.
The citalopram combination was not as successful as the fluoxetine combination, but a decrease
also occurred. The citalopram and 0.1-mg/kg dose of JWH-018 caused an average of3.625
marbles to be buried, which is not significantly different the citalopram test. The 0.3-mg/kg of
JWH-018 combination was significantly different at 2.875 marbles buried. These results can be
seen graphically in Figure 10.
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Figure 11 : Marbles Buried for Rimonabant Combination
Figure 11 shows the results of the last test that occurred after the main experiment had
ended. The first bar is the same control as was used in the original experiment, 6.375 marbles
buried. The second bar is the 10-mg/kg fluoxetine result from the previous experiment (4.25
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marbles buried), and the third bar is the combination of 0.3-mg/kg JWH-0 18 and fluoxetine from
the previous experiment (1.875 marbles buried). The final bar was the same 0.3-mg/k.g JWH0 18 and 10-mg/k.g fluoxetine combination as before, but 10-mg/kg rimonabant was added to the
combination. When rimonabant was added to the experiment, the amount of marbles buried was

3.375.

Conclusions
Co-administration of JWH-018 and both SSRls, fluoxetine and citalopram, resulted in a
greater than anticipated drug effect as was hypothesized. The increased drug effect with the
synthetic cannabinoid and fluoxetine was expected, but it was not expected to occur with
citalopram. Citalopram was a positive control, since it did not share the same enzyme as the
other two compounds, which means that there is likely a pharmacodynamic aspect to the
increased drug effect. The evidence that the effect is pharmacodynamic goes against the initial
hypothesis. Also, the results of the rimonabant experiment support a pharmacodynamic
interaction, since the inclusion of rimonabant reduced the additional effect of the combination.
These results are significant since they illustrate how co-administration of the two types
of compounds can result in high dose effects at low doses. The greater breadth of increased
effect than expected will also warrant more tests with a variety of SSRls and other antidepressant medication. It will also mean that the increase in synthetic cannabinoid abuse with
common prescription drugs may resu1t in more hospitalizations or potential deaths.
There are many futme experiments that could be useful in examining the interaction
between these drugs. First, having more trials of the current tests would help to validate what

has already been done, but changing from a longitudinal experiment design could be helpfuL
Mice could be used in a control test and then two other tests before being replaced. This would
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help to eliminate any changes in marble burying that occurred due to tolerance, sensitivity or
dependence. Mice being used for a shorter time would al so help increase the sample size, which
would help prevent outliers from skewing any results.
Tests that examined the effects of chronic use of these compounds could also be
interesting. Either JWH-018 or an SSRI could be given chronically then an acute injection of the
other drug could be given with a treatment time before the marble burying test is administered.
SSRis are taken daily, so it would be relevant to see the chronic effects. Synthetic cannabinoids
can also be abused chronicaliy, so giving either drug chronically before an acute injection would
be relevant.
More testing is imperative so that more information can be observed regarding the effects
of synthetic cannabinoids and SSRls together. SSRis are already one of the most commonly
prescribed types of antidepressants, and synthetic cannabinoids abuse has been increasing for
years. The use of these drugs together can cause many negative health em~L'fs, but continued tests
such as these can help prepare for abuse of these drugs in the future.
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